Omega Therapeutics "announced that it has entered into a securities purchase agreement with investors in a registered direct offering of 6,920,415 shares of common stock at a purchase price of $5.78 per share, resulting in gross proceeds of approximately $40 million. The offering included participation by new and existing investors."
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on OMGA:
